It has been reported that the activation of the signaling cascades associated with BRAF and PTEN mutations, two major alterations frequently found in advanced PTCs, results in thyrocytes in the development of PTC with a fibrotic and reactive tumor stroma in a transgenic mouse model [87]. Here, BRAF is linked to neoplasm.